MDT
Medtronic PLC
Medtronic PLC historical holders
total: 12
Mairs & Power Growth Fund Medtronic PLC transactions over time
- Total transactions:
- 13
- New positions:
- 1
- Sold out:
- 1
- Added:
- 4
- Reduced:
- 7
- Held since:
- 2019 Q3
- Held for:
- 21 quarters
- Latest activity:
- 2024 Q4
Mairs & Power Growth Fund has been an institutional investor in Medtronic PLC (MDT) since 2019 Q3. According to 2026 Q1 report, Mairs & Power Growth Fund doesn't hold any shares. The fund/company first acquired MDT in 2019 Q3, initially purchasing about 1.73M shares. Since the initial investment, Mairs & Power Growth Fund has made 12 more transactions in this position.
When did Mairs & Power Growth Fund exit their MDT position?
Mairs & Power Growth Fund no longer holds Medtronic PLC (MDT). They sold off their entire position in 2024 Q4, closing out an investment that began in 2019 Q3.
When did Mairs & Power Growth Fund first invest in MDT?
Mairs & Power Growth Fund first invested in Medtronic PLC (MDT) in 2019 Q3 at the reported quarter-end price of $108.62 per share, acquiring 1,728,200 shares in their initial purchase.
What is Mairs & Power Growth Fund's average cost basis for MDT?
Based on historical transaction data, Mairs & Power Growth Fund's estimated cost basis for Medtronic PLC (MDT) is approximately $104.49 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $104.49
- Weighted AVG sell price:
- $92.89
MDT transactions history by Mairs & Power Growth Fund
13 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2024 Q4
|
0.00%
|
0
|
$90.03
|
|
-100% (-981,000)
|
-1.55%
|
|
2024 Q3
|
1.55%
|
981,000
|
$90.03
|
$88,319,430
|
-44.26% (-779,000)
|
-1.26%
|
|
2023 Q3
|
3.06%
|
1,760,000
|
$78.36
|
$137,913,600
|
+8.37% (+136,000)
|
+0.24%
|
|
2022 Q3
|
3.10%
|
1,624,000
|
$80.75
|
$131,138,000
|
+9.14% (+136,000)
|
+0.26%
|
|
2022 Q2
|
2.99%
|
1,488,000
|
$89.75
|
$133,548,000
|
-1.65% (-25,000)
|
-0.04%
|
|
2022 Q1
|
3.09%
|
1,513,000
|
$110.95
|
$167,867,350
|
-6.02% (-97,000)
|
-0.18%
|
|
2021 Q3
|
3.69%
|
1,610,000
|
$125.35
|
$201,813,500
|
-1.53% (-25,000)
|
-0.06%
|
|
2021 Q2
|
3.68%
|
1,635,000
|
$124.13
|
$202,952,550
|
-3.82% (-65,000)
|
-0.16%
|
|
2021 Q1
|
3.93%
|
1,700,000
|
$118.13
|
$200,821,000
|
-1.73% (-30,000)
|
-0.07%
|
|
2020 Q3
|
4.10%
|
$103.92
|
+3.90% (+65,000)
|
|||
|
2020 Q2
|
3.65%
|
$91.70
|
+1.52% (+25,000)
|
|||
|
2020 Q1
|
4.07%
|
$90.18
|
-5.10% (-88,200)
|
|||
|
2019 Q3
|
4.28%
|
$108.62
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.